NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Caribou Biosciences (CRBU – Research Report) today. The company’s ...
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results